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Abstract
Background: Predicting metabolic sites is important in the drug discovery process to aid in rapid compound 
optimisation. No interactive tool exists and most of the useful tools are quite expensive.
Results: Here a fast and reliable method to analyse ligands and visualise potential metabolic sites is presented which is 
based on annotated metabolic data, described by circular fingerprints. The method is available via the graphical 
workbench Bioclipse, which is equipped with advanced features in cheminformatics.
Conclusions: Due to the speed of predictions (less than 50 ms per molecule), scientists can get real time decision 
support when editing chemical structures. Bioclipse is a rich client, which means that all calculations are performed on 
the local computer and do not require network connection. Bioclipse and MetaPrint2D are free for all users, released 
under open source licenses, and available from http://www.bioclipse.net.
Background
Metabolic stability is a critical aspect in the drug discov-
ery process. A candidate drug faces a system that has
evolved to prevent exposure of foreign compounds in the
body by metabolising enzymes. Xenobiotic metabolism
mainly occurs in two places; the gut epithelia and the
liver. The mechanisms are quite well understood, but
there is still a tremendous variation in reactions that lead
to biotransformations. Many enzymes can carry out the
same reactions on a variety of substrates. All together the
metabolising systems are hard to model with high accu-
racy.
The currently available predictive tools are usually
tuned and validated against literature data, and few avail-
able methods rapidly present the results in a simple inter-
face. A simple database search only shows the exact
reported literature results and quite cumbersome queries
are needed to retain any information at all about probable
sites of metabolism [1]. Much of the data in the literature
have been collected by Symyx(R) http://www.symyx.com
and they provide a tool, ISIS, to search for structures and
other entities to retrieve putative metabolic sites. The
data have been curated and is regarded to be of high qual-
ity. Another tool is Metasite [2] which predicts metabolic
sites in a semi-deterministic fashion. Another method
uses historic metabolic biotransformation data from the
literature exclusively [3]. These methods are all fairly
accurate [4] and provide chemists with results within a
reasonable time. However, none of them is interactive
and allows a user to get instant updates during editing of
chemical structures, and some of them are only available
under expensive licenses that restrict their availability.
Also available is Meteor [5], which is easy to use and gives
reasonably clear results. But, it generates many possible
metabolites that perhaps are not all probable. To fully
make use of all different features in some of the tools, a
substantial amount of computer knowledge is required.
There is a need for fast, reliable, and easy to use method
for site-of-metabolism predictions.
This paper describes an interactive tool for prediction
of metabolic sites that can run on a desktop and be man-
aged by "wet-lab chemists". It has been built by combin-
ing two existing applications Bioclipse [6] and
MetaPrint2D based on [3]. The next section explains how
the two components work and how they have been com-
bined, followed by a section where results are presented
* Correspondence: lars.a.carlsson@astrazeneca.com
1 Safety Assessment, AstraZeneca Research & Development, 431 83 Mölndal, 
Sweden
Full list of author information is available at the end of the articleCarlsson et al. BMC Bioinformatics 2010, 11:362
http://www.biomedcentral.com/1471-2105/11/362
Page 2 of 7
to illustrate its use and performance, ending with discus-
sions about the implications.
Methods
MetaPrint2D
MetaPrint2D is a tool for predicting the sites of a mole-
cule that are most likely to undergo Phase I metabolism,
based on their similarity to known sites of metabolism
and sites that are known not to be metabolised. The
method builds on a database of atom environments found
in molecules known to undergo metabolic transforma-
tion, such as the data found in the Symyx(R) (previously
MDL) Metabolite database http://www.symyx.com/,
which contains over 80.000 metabolic transformations of
xenobiotics, curated from reports in scientific literature.
MetaPrint2D contains a complete enumeration of the
a t o m e n vir o nm e n ts  oc cu rring  in r ea ctan t  m olecul es  in
the Metabolite database, together with counts of the
number of occurrences of the atom environment at a
reaction centre, and anywhere in the database, whether at
a reaction centre or not.
In order to make predictions on a molecule the atom
environments in the molecule are calculated, and the
database is searched for similar environments. An occur-
rence ratio - measuring how often this or a similar envi-
ronment has been found at a reaction centre, relative to
how many times it has been observed in total -is then cal-
culated for each atom in the molecule. These ratios repre-
sent the relative likelihood of metabolism occurring at
each atom; no prediction is made as to whether the mole-
cule does indeed undergo metabolism, rather a ranking of
the likelihood of metabolism occurring at each site in the
molecule is produced. In order to standardise the output,
these ratios are then scaled so that the molecule's most
likely site of metabolism gets a normalised occurrence
ratio of one.
Preprocessing
The MetaPrint2D data is generated through processing of
the transformations found in the Symyx(R) Metabolite
database. For each transformation, the differences
between the structure of the reactant and product are
identified: groups added or eliminated, bonds broken or
made and bonds whose order has changed. In order to
simplify the results, only Phase I additions (defined as the
addition of a single oxygen atom; covering hydroxylation,
oxidation and epoxidation), and eliminations (for exam-
ple dealkylation, ester and amide hydrolysis) are retained.
For an addition, the atom neighbouring the added oxygen
is marked as a reaction centre. In the case of an elimina-
tion, a bond gets broken, and both atoms connected by
the bond are considered to be reaction centres.
The preprocessing is continued by a generation of cir-
cular fingerprints [7,8] for each reaction centre and also
for every atom in the reactants. Circular fingerprints
(also known as spherical fingerprints) represent the
chemical environment of an atom in a form that can be
processed by a computer (Figure 1). These fingerprints
include the number of occurrences of atoms of various
types in each of a series of concentric layers radiating out
from a central atom; the first layer contains the atom the
environment is centred on, and each subsequent layer
contains the immediate neighbours of the atoms in the
previous layer, so the second layer contains those atoms
directly bonded to the central atom, and the third layer
contains the atoms directly bonded to those atoms in the
second layer. An atom environment can extend to an
arbitrary number of layers. MetaPrint2D utilises environ-
ments up to six layers in depth. Rather than describing
atoms by their chemical element, they were described
using the implementation of Tripos forcefield atom types
in the Chemistry Development Kit [9], which combine
the atom's chemical element with its hybridisation and
aromaticity. The used Sybyl atom types were C.3, C.2,
C.ar, C.1, N.3, N.2, N.1, O.3, O.2, S.3, N.ar, P.3, H, Br, Cl, F,
I, S.2, N.pl3, LP, Na, K, Ca, Li, Al, Du, Si, N.am, S.O, S.O2,
N.4, O.CO2, and C.cat. Thus for each unique circular fin-
gerprint the occurrence as a reaction centre as well as the
overall occurrence is stored in the following sparse for-
mat (in our Java implementation):
int numberOfFingerprints //All finger-
prints from the
  //transformation db.
byte numberOfLevels //Fingerprint levels.
  //We only use six.
Figure 1 Circular fingerprints. An illustration of a three-level atom 
environment. The atom the environment is calculated for is at the cen-
tre of the environment, labelled black in this figure, and the atoms in 
the second and third layers are labelled light and dark grey, respective-
ly. Carlsson et al. BMC Bioinformatics 2010, 11:362
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//For each fingerprint
byte numberOfNonZeroEntries // All exist-
ing atoms.
//For each non-zero entry
byte index // The index representing the
Sybyl atom type.
byte value // The occurrence of a specific
Sybyl atom type
int rc // Number of occurrencs as reaction
centre.
int oc //Number of occurrences overall.
byte errorCheckingByte // Always set to a
unique value.
Predictions
T he second stage of the proposed method is what the
u s e r  e x p e r i e n c e s .  I t  s t a r t s  b y  r e a d i n g  a  f i l e  o f  p r e p r o -
cessed transformation data, putting all fingerprints with
their associated information, such as number of occur-
rences as reaction centres and number of occurrences
overall in reactants, in memory. All atoms of a query mol-
ecule undergo the same procedure to generate circular
fingerprints based on Sybyl atom types and to allow for
comparison to the reactants of the underlying transfor-
mation database. In addition to the steps of generating
the circular fingerprints, a hashcode, h, is generated for
each fingerprint level by the following recurrence
sequence:
where si is the sum of a specific Sybyl atom type, repre-
sented by the index i and α is an integer constant. The
preprocessed transformation data is searched by collect-
ing all circular fingerprints with identical hashcodes, for a
predefined number of levels, to each atom fingerprint in a
query molecule. The hashcode is a compact representa-
tion of a fingerprint which is optimised for comparisons,
where two identical hashcodes are not necessarily repre-
senting identical fingerprints but two identical finger-
prints have identical hashcodes. If an atom fingerprint in
a query molecule, Fq, and a transformation molecule
atom fingerprint, Ft, are considered to be similar the fol-
lowing needs to be true:
where N is the number of fingerprint levels required for
an exact match, wl is a weight that can be set for each fin-
gerprint level and ε is a similarity threshold. By searching
the transformation data fingerprints using the hashcodes,
the number of fingerprints searched using the similarity
operator in Equation 3 is substantially reduced without
any loss of information. The sum of both the reaction
centre occurrences and the overall occurrences for all
similar transformation data fingerprints are stored for
each query atom, respectively. These ratios are also nor-
malised by the greatest ratio within a query molecule for
an easy overview and a possible rank order for predicted
sites of metabolism.
Bioclipse
Bioclipse [6] is a graphical workbench for life science
which is equipped with tools required for many common
cheminformatics tasks, such as loading and converting
between file formats, editing of chemical structures,
interactive visualisation in 2D/3 D, and editing of com-
pound collections. Bioclipse is however not limited to
this; its extensible architecture enables it to be extended
into virtually any direction, and has been used in such
various fields as drug discovery, bioinformatics, spectral
analysis, high throughput screening, systems biology, and
general chemistry education. As a rich client application,
Bioclipse is downloaded and installed onto desktop com-
puters, and is able to utilise their full power while also
taking full advantage of new e-Science technologies, such
as on-line (Web) services, high-performance computing,
and networked databases. Equipped with an advanced
provisioning system, it is very easy to publish updates for
Bioclipse. This not only simplifies maintenance, but also
enables users to stay up to date and always use the most
current version of algorithms and data.
Results and Discussion
Version 1.0 of of MetaPrint2D has been trained using the
2008.1 version of the Symyx(R) Metabolite database. Four
different MetaPrint2D databases are currently provided,
one generated from all the transformations in the Metab-
olite database, and others generated only using transfor-
mations found to occur in particular species - human, rat
and dog. For the layered fingerprint hashcodes, α was set
to 16 and N (number of exact levels) was set to 3.
A MetaPrint2D plugin for Bioclipse was created which
adds several new options for visualising chemical struc-
tures. A specific toolbar and a menu allows the user to
select one of the available MetaPrint2D databases (All,
Human, Dog, or Rat), adds options for selecting search
mode, and also provides means to execute the
MetaPrint2D calculation and to visualise the result in the
chemical structure. Currently the file formats MDL Mol-
file, Chemical Markup Language (CML), SMILES, and
Structure Data File (SDF) are supported, and results can
be visualised for single molecules or multiple structures
in a table. It is also possible to execute MetaPrint2D in
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batch mode, and process for example SD files containing
large collections of structures without visual inspection.
MetaPrint2D is also accessible from the Bioclipse script-
ing language and can easily be integrated in custom Bio-
clipse scripts to automate tasks (for an example, see [10]).
Running a MetaPrint2D prediction is easy within Bio-
clipse. The Navigator pane on the left hand side (Figure 2)
allows for management of files and folders that can be
operated upon in Bioclipse, and points to a place on the
local hard disk. The Navigator is easily populated by drag
and drop or cut and paste of files and/or folders, or using
the Import functionality of Bioclipse. Opening a single
molecule in the 2 D editor or multiple molecules in the
Molecules Table of Bioclipse reveals the MetaPrint2D
toolbar, allowing for MetaPrint2D calculations. The
results are visualised so that atoms are coloured accord-
ing to the likelihood of a metabolic site being centred on
this atom: High: red, Medium: yellow, Low: green, and
Very low is not coloured. In single molecule mode the
molecule can be edited and by a click of a button the new
prediction is computed and displayed, or automatic pre-
diction is turned on and a new prediction is executed
upon changing the structure. Figure 2 shows the drug
Verapamil opened in Bioclipse, and coloured by
MetaPrint2D analysis using the Standard search mode
and the database ALL. Hovering over an atom reveals a
tooltip showing the number of hits in the reaction centre
set, the total number of hits, and the normalised occur-
rence ratio. It is simple to edit the chemical structure and
update the visualisation; the process is near real-time
which makes it very easy to explore changes to the struc-
ture that affect the likely site of metabolism.
It is straightforward in Bioclipse to invoke MetaPrint2D
on files containing multiple molecules. Figure 3 shows an
SD file opened and predicted in Bioclipse. The same
colouring as in single molecule mode is produced, and
the user can switch between this tabular view of several
compounds to a more detailed view of a single compound
by selecting the Single Molecule tab in the bottom of the
table. Here the user can make desired structural changes
to a compound, and then switch back to the tabular view
and proceed to another compound in the collection.
There is also the ability to execute MetaPrint2D in batch
mode by right-clicking a file and selecting "Run
MetaPrint2D". An SD file comprising 232 compounds
(available in suppl. material) with 20 atoms on average
was subjected to MetaPrint2D calculation in batch mode
using Standard search mode and the database ALL. The
file took 8.1s to process, which is an average of 34 ms per
molecule. All results were measured on a MacBook Pro
laptop using Bioclipse version 2.4, MetaPrint2D Bioclipse
plugin version 1.0, MetaPrint2D version 1.0, and
Symyx(R) Metabolite database 2008.1.
The source code for the MetaPrint2D algorithm is
available from Sourceforge [11], and this version can be
used as a standalone calculator called from the command
line. The source code from the Bioclipse-MetaPrint2D
plugin is available from Github [12], and a page describ-
ing the Bioclipse integration is also available [13]. A web
page for demonstrating MetaPrint2D is available [14];
note however that the MetaPrint2D version on the web
page might differ from the version included in the Bio-
clipse-MetaPrint2D plugin and what is described herein.
Conclusions
We here present MetaPrint2D, which is an improved
algorithm for site-of-metabolism prediction. The effi-
cient use of layered, hashed circular fingerprints signifi-
cantly improves the speed of predictions over Boyer et al.
(2007), and allows for use in new applicability domains.
For example it is possible to try different hypothesis
regarding chemical structures with instant feedback,
which for the first time makes site-of-metabolism predic-
tion a feasible methodology to integrate with a chemical
drawing application. The combination of MetaPrint2D
and Bioclipse greatly simplifies site-of-metabolism pre-
dictions in the eyes of scientists. The MetaPrint2D algo-
rithm has proven to be extremely fast compared to other
available tools, and opens up the possibility to perform
site-of-metabolism predictions on a large scale. The inte-
gration into Bioclipse extends the usability and accessibil-
ity of MetaPrint2D, and in contrast to existing tools,
predictions can now be done on regular laptops at execu-
tion times that are considerable less than one second per
molecule. The implementation does not require access to
remote computers, and the accuracy of the predictions to
the predecessor of MetaPrint2D has been shown to be on
par with other tools in the field [4].
The intuitive user interface in Bioclipse enables
MetaPrint2D to be used by a variety of people in the drug
discovery process, ranging from computational chemists
to experts in drug metabolism. Molecules can easily be
drawn in the chemical editor of Bioclipse and then sub-
jected to MetaPrint2D prediction, or predictions can be
made on all molecules in a file. The real time execution
provided in single molecule mode allows for the user to
try different hypothesis with very little effort, and get
instant feedback of the predicted site of metabolism for a
change in the chemical structure of a compound. The
option to visualise multiple predictions in a tabular view
allows for simultaneously working with collections of
compounds with the same functionality, and easy switch-
ing to editing individual compounds. For larger collec-
tions or when visual inspection is not desired, the batch
functionality for running predictions on a file with results
stored as properties is an appealing option. For more
advanced users, Bioclipse provides the means to callCarlsson et al. BMC Bioinformatics 2010, 11:362
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Page 5 of 7
MetaPrint2D from within a Bioclipse script and integrate
it with other applications. The advanced provisioning
system of Bioclipse greatly facilitates updates to the
implementation and the databases of the MetaPrint2D
plugin.
Open-source software provides excellent opportunities
to extend and combine different software projects. The
application presented here is an example of this and there
are several benefits of this: 1) It is completely free of
charge, 2) Anyone who has ideas on how to improve the
algorithms can either contribute to any of the two proj-
ects or take all available software and tailor it for their
own specific needs, and 3) The access to the source code
ensures reliability and builds trust. There are no hidden
Figure 2 MetaPrint2D in Bioclipse showing a prediction on the drug Verapamil. Screenshot from Bioclipse with the results from a MetaPrint2D 
calculation on the drug Verapamil using the Standard search mode and the database ALL. Atoms coloured in red indicates a high likelihood of me-
tabolism occurring at that site, yellow indicates medium, green low, and no colouring indicates very low or no likelihood of metabolism occurring at 
that site. Hovering over an atom reveals a tooltip showing the number of hits in the reaction centre set, the total number of hits, and the normalised 
ratio.Carlsson et al. BMC Bioinformatics 2010, 11:362
http://www.biomedcentral.com/1471-2105/11/362
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details and everything can be reproduced. Both
MetaPrint2D and Bioclipse are released under open
source licenses and are completely free of charge.
Appendix A: Availability
Getting Bioclipse and MetaPrint2D
A Bioclipse plugin enabling the use of the MetaPrint2D
library from within Bioclipse is available. Bioclipse must
be downloaded and installed from http://www.bio-
clipse.net. The easiest way to install MetaPrint2D is to
use the option Software Updates from the Help menu in
Bioclipse. Bioclipse will then contact the update server
and present the user with a list of features that is available
for installation. By checking MetaPrint2D and clicking
"Add required plugins", the MetaPrint2D functionality is
available after restart (a new menu, a toolbar and context
m e n u  a c t i o n s )  w h e n  b r o w s i n g / e d i t i n g  c h e m i c a l  s t r u c -
tures and files.
The source code of the MetaPrint2D library is available
from http://sourceforge.net/projects/metaprint2d/.
Figure 3 MetaPrint2D in Bioclipse showing predictions on multiple molecules. Screenshot from Bioclipse with the results from a MetaPrint2D 
calculation of an SD file illustrating four well known drugs using the Standard search mode and the database ALL. This gives an informative overview 
when working with collection of molecules, and it is simple to switch to editing individual molecules using the 2D-structure view.Carlsson et al. BMC Bioinformatics 2010, 11:362
http://www.biomedcentral.com/1471-2105/11/362
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License
Bioclipse is released under Eclipse Public License (EPL)
[15]. EPL is a flexible open source license that ensures
core plugins will remain open source, but sets no con-
straints on external plugin licensing. More information
can be found on the Bioclipse home page. MetaPrint2D
1.0 is released under GNU Lesser General Public License
(LGPL) [16].
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